Nuvation Bio (Nuvation Bio) Capex-to-Revenue : 0.00 (As of Sep. 2021)

View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Nuvation Bio's Capital Expenditure for the three months ended in Sep. 2021 was $-0.03 Mil. Its Revenue for the three months ended in Sep. 2021 was $0.00 Mil.

GuruFocus do not calculate Capex-to-Revenue if the revenue is negative.

Nuvation Bio Capex-to-Revenue Historical Data

The historical data trend for Nuvation Bio's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio Capex-to-Revenue Chart

Nuvation Bio Annual Data

Trend

Dec20

Dec21

Capex-to-Revenue

Nuvation Bio Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21
Capex-to-Revenue	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Nuvation Bio's Capex-to-Revenue

For the Biotechnology subindustry, Nuvation Bio's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nuvation Bio's Capex-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuvation Bio's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Nuvation Bio's Capex-to-Revenue falls into.

Nuvation Bio Capex-to-Revenue Calculation

Nuvation Bio's Capex-to-Revenue for the fiscal year that ended in Dec. 2020 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (0)	/	0
	=	N/A

Nuvation Bio's Capex-to-Revenue for the quarter that ended in Sep. 2021 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-0.029)	/	0
	=	N/A

Nuvation Bio (NYSE:NUVB.WS) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Nuvation Bio Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuvation Bio (Nuvation Bio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB.WS) » Definitions » Capex-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

1500 Broadway, Suite 1401, New York, NY, USA, 10036

Website

https://www.nuvationbio.com

Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.